Next Article in Journal
Accessing Dietary Effects on the Rumen Microbiome: Different Sequencing Methods Tell Different Stories
Previous Article in Journal
Digital Lesions in Dogs: A Statistical Breed Analysis of 2912 Cases
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Seroprevalence and Risk Factors Associated with Brucella Infection in Camels in the Puntland State of Somalia

1
Department of Disease Control, School of Veterinary Medicine, The University of Zambia, Lusaka P.O. Box 32379, Zambia
2
Faculty of Veterinary Medicine, Red Sea University, Galkayo RC2F+WC, Somalia
3
Department of Animal Health and Livestock Development, BLADD, Mpemba P.O. Box 34, Malawi
4
Department of Public Health, Michael Chilufya Sata School of Medicine, The Copperbelt University, Ndola P.O. Box 71769, Zambia
5
Department of Environmental Health, School of Medicine and Health Sciences, Eden University, Lusaka P.O. Box 37727, Zambia
6
Department of Arctic and Marine Biology, UiT—The Arctic University of Norway, 9037 Tromsø, Norway
*
Author to whom correspondence should be addressed.
Submission received: 19 May 2021 / Revised: 27 June 2021 / Accepted: 29 June 2021 / Published: 19 July 2021

Abstract

:
Brucellosis is an important zoonotic disease caused by members of the genus Brucella. Camel brucellosis has been reported in almost all camel-rearing countries in Africa and Asia. A cross-sectional study was conducted between February 2020 and February 2021 in Galkayo, Garowe, and Bosaso districts in the Puntland State of Somalia to investigate the seroprevalence and risk factors of brucellosis in camels. A competitive enzyme-linked immunosorbent assay (c-ELISA) was used to detect anti-Brucella antibodies, while a structured questionnaire was used to collect epidemiological data. A total of 441 camel sera were screened against Brucella antibodies. Thirty-one (7%; 95% CI: 4.8–9.8%) samples were positive, and thirteen (54.2%; 95% CI: 32.8–74.4%) out of the twenty-four farms sampled had at least one seropositive animal. Galkayo district had the highest number of Brucella-seropositive camels (10.3%), followed by Bosaso district (8.6%), while Garowe district had the lowest number of seropositive camels (1.4%). The binary logistic regression model revealed that camels in Galkayo district (p = 0.015; OR: 9.428; 95% CI: 1.539–57.755), camels from large herd sizes of >50 animals (p = 0.019; OR: 5.822; 95% CI: 1.336–25.371), and those in contact with small ruminants (p = 0.011; OR: 10.941; 95% CI: 1.728–69.285) were significantly associated with seropositive cases of camel brucellosis in the Puntland State of Somalia. The present study shows that Brucella infections in camels are prevalent in the three districts covered by the study. This poses a public health risk, because milk from these camels is used for human consumption. Studies focusing on the isolation of Brucella strains in camels and investigating brucellosis in ruminants and humans are recommended in the study area. Validation of serological tests—including c-ELISA—for Brucella antibody detection in camels is also needed.

1. Introduction

Somalia has the world’s largest dromedary camel (Camelus dromedarius) population, with more than seven million [1]. In addition to their social and cultural importance to Somali pastoralists, camels play a vital role in food security and national economy in the country. Interest in dromedary camel (one-humped camel) rearing has increasingly developed in arid countries, including Somalia, as dromedaries are more drought tolerant than any other domestic animals [2]. Camels are not only kept for milk, but also provide meat, and are used as a means of transportation. As a result of camels being the main source of milk in Somalia, intensification of camels for milk production in many parts of the country was started in the last few years.
Camels are, however, affected by a number of diseases, including brucellosis. Brucellosis is an important zoonotic disease caused by members of the genus Brucella. The disease can affect almost all domestic animals, and cross-transmission can occur between cattle, sheep, goats, and camels [2]. Brucella infection in camels is mainly caused by B. abortus and B. melitensis. Camels are not known to be the primary host for Brucella spp., and infection in camels depends on contact with other primary host animals [3]. Clinical disease in camels is very rare; however, infected camels are silent carriers of the Brucella pathogen, and the possible shedding of the organism in the milk may lead to transmission of the pathogen to humans [4,5,6]. Additionally, this disease imposes restrictions on the livestock trade.
Camel brucellosis has been reported in most camel-rearing countries in Africa and Asia [7]. In East Africa, camel brucellosis has been reported in Somalia, Ethiopia, Kenya, Sudan, and Eritrea [2]. However, there are no sufficient data about the real status of the disease in many countries of the world, and research on the epidemiology of camel brucellosis is very scarce [8,9]. Despite the fact that no test has been specifically validated in camels, a number of serological tests—including RBPT, ELISA, and the complement fixation test (CFT)—can be used for the diagnosis of camel brucellosis [10].
There is sufficient evidence indicating that brucellosis is present in sheep and goats [11,12], cattle [13,14], camels [3,15], and humans [16] in Somalia. However, there is currently little information available about the epidemiology of the disease in Somalia, and its occurrence in both livestock and humans is poorly estimated. Few studies have been conducted in south and central Somalia, or in Somaliland (northern Somalia) [3,15]. One study reported 3.9% individual seroprevalence in camels in northern Somalia [3], while 4.4% individual seroprevalence of camel brucellosis was reported in Mogadishu, southern Somalia [15]. However, no information is available on camel brucellosis in the Puntland State of Somalia (northeastern Somalia). According to the Food and Agriculture Organization of the United Nations (2014), livestock exports—especially sheep, goats, cattle, and camels—are the most traded commodity in Somalia. Brucellosis can hinder this huge livestock trade in the country.
Furthermore, many Somali people consume raw camel milk without heat treatment [15]; thus, Brucella-infected camels can pose health risks to the camel milk consumers in the country. Currently, there is no national control program for brucellosis in Somalia—a situation that might lead to spread of the disease among animals, resulting in huge economic losses to the livestock industry and negatively impacting public health. Therefore, this study was designed to investigate the seroprevalence and potential risk factors of brucellosis in camels in northeastern Somalia (the Puntland State of Somalia).

2. Materials and Methods

This study was conducted in the Puntland State of Somalia, a federal member state in northeastern Somalia. Puntland is bordered by Somaliland to its west, the Gulf of Aden to the north, the Indian Ocean to the east, the central Galmudug region to the south, and Ethiopia to the southwest. Puntland is semi-arid, with an average daily temperature range of 27–37 °C. The total area of the state is about 212,510 km2, with a population estimated at 4,334,633 in 2016 [17]. According to the Intergovernmental Authority on Development (IGAD) Centre for Pastoral Areas and Livestock Development (ICPALD), the estimated camel population stands at 1,868,000 in the Puntland State of Somalia as of 2013 [18]. Camels in Puntland State are mainly raised for milk and meat production under a nomadic system using traditional husbandry practices. However, commercialization of dairy camels, and keeping them in a semi-intensive production system, began in the last few years.
This cross-sectional study was conducted between February 2020 and February 2021, to determine the seroprevalence and risk factors of brucellosis in camels in the Puntland State of Somalia. Three districts were covered—namely, Bosaso (in the Bari region), Garowe (in the Nugal region) and Galkayo (in the Mudug region). Only commercially kept dairy camels were targeted, and these three districts were purposely selected because they represent the main dairy camel farming areas in the state. The number of animals to be sampled was calculated based on an assumed individual Brucella seroprevalence (unknown seroprevalence) of 50%, within a 95% confidence level and 5% desired precision. Sample size was obtained using the following formula [19]:
n = 1.96 2 × Pex × ( 1 Pex ) ( d ) 2
where n = sample size, d = desired absolute precision, and Pex= expected prevalence; thus, the desired sample size for Pex = 0.5 was n = 384. To account for non-response, a 10% adjustment was made, bringing the required sample size to 423 camels. However, at the end of the study, 441 camels were sampled.
A proportionally representative sample was allocated to each district based on its estimated number of dairy camel farms. A list of dairy camel farms in each district was obtained from the veterinary authority and from locals, and farms were selected randomly. All eligible animals were randomly sampled on every farm with ≤20 animals. For farms with larger herd sizes, a maximum of 30 animals were sampled from each herd. Each unvaccinated dairy camel commercially reared under the semi-intensive production system and above six months of age was included in the study. A structured questionnaire preloaded into smart phones using Epicollect5 (https://five.epicollect.net/, accessed on 8 December 2019) was administered in order to collect risk factors for brucellosis in camels. Information for each camel sampled was obtained, including age, sex, and history of abortion over the last two years. Information on each herd sampled was also obtained, including herd size, contact with ruminants, introduction of new camels to the herd, vaccination status, contact with other camel herds, and history of abortion in the herd over the last two years.
About 5 mL of whole blood sample was collected from the jugular vein, using plain vacutainer tubes and needles, from each camel. Sera were stored at −20 °C until being transported to the University of Zambia and tested via competitive enzyme-linked immunosorbent assay (c-ELISA). Sera samples were tested in singlicate. The c-ELISA test was conducted using the SVANOVIR® Brucella-Ab c-ELISA kit and performed according to the manufacturer’s instructions. Any test sample with percentage inhibition (PI) < 30 was considered negative, and any test sample with PI > 30 was considered positive, according to the c-ELISA kit guide.
Data were analyzed using IBM SPSS Statistics 21. Seroprevalence and 95% confidence intervals (CIs) were computed. Potential risk factors associated with Brucella-seropositive cases at the individual animal level were initially screened via chi-squared test in univariate analysis. Moreover, all variables with p ≤ 0.25 in univariate analysis were used to construct a backward stepwise binary logistic regression model, and the degree of association was computed using odds ratios (ORs) and 95% confidence intervals (CIs).

3. Results

3.1. Distribution and Characteristics of Sampled Camels

A total of 441 camels in 24 herds from the Galkayo (185 camels), Garowe (140 camels), and Bosaso (116 camels) districts were examined. Of these, 346 (78.5%) were female, and 95 (21.5%) were male. The average herd size in the three districts was 65 animals per herd; 10 (41.7%) herds had <50 camels, while 14 (58.3) herds had >50 camels. The majority of the examined camels (251 camels) were older than 5 years (Table 1).

3.2. Seroprevalence of Camel Brucellosis

Out of the 441 tested serum samples, 31 (7%; 95% CI: 4.8–9.8%) were positive, while 13 (54.2%; 95% CI: 32.8–74.4%) of the 24 farms sampled had at least one seropositive camel. Regarding the seroprevalence of camel brucellosis in the three districts, Galkayo district had the highest number of c-ELISA-seropositive camels (10.3%), followed by Bosaso district (8.6%), while Garowe district had the lowest number of seropositive camels (1.4%) (Table 2).

3.3. Univariate Analysis of Risk Factors for BrucellaInfection in Camels

The results of the chi-squared cross-tabulation are presented in Table 3. Only variables with p ≤ 0.25 were further analyzed in the binary regression. No analysis was possible for contact with other camels, vaccination status, or ranging system, because all sampled camels were unvaccinated, had contact with other camel herds, and ranged freely.
In the multivariate logistic regression model at the individual level, Hosmer–Lemeshow goodness of fit test results showed that the model adequately fitted the data (X2= 0.229; p =0.994). The binary logistic regression model revealed that the camels in Galkayo district (p = 0.015; OR: 9.428; 95% CI: 1.539–57.755), camels from large herd sizes of >50 animals (p = 0.019; OR: 5.822; 95% CI: 1.336–25.371), and camels in contact with small ruminants (p = 0.011; OR: 10.941; 95% CI: 1.728–69.285) were positively associated with seropositivity for camel brucellosis in the Puntland State of Somalia (Table 4).

4. Discussion

The aim of this study was to describe the epidemiology of Brucella infection in semi-intensively kept dairy camels in the Puntland State of Somalia. We recorded a seroprevalence of 7%, and identified the area of production (districts), herd size, and contact with small ruminants to be major risk factors for Brucella infections in camels.
Based on the c-ELISA results, the individual seroprevalence of camel brucellosis in this study was estimated at 7%; this is the highest seroprevalence of camel brucellosis reported in Somalia. Despite the fact that there is no c-ELISA assay specifically validated in camels, the assay is widely used in the diagnosis of camel brucellosis [20]. Further, a study by Sayour et al. (2015) suggests that c-ELISA is an excellent test for the detection of Brucella antibodies in camels, but needs further standardization in camel sera [21]. The findings of the current study disagree with the studies conducted in southern northern Somalia [3,15], which reported lower seroprevalence of 3.9% using both SAT and c-ELISA, and 3.1% using i-ELISA, respectively. These results also contrast with studies reported in Ethiopia, where the seroprevalence was 2.2% [22], 4.1% [23], and 3.37% [24]. Seroprevalence of camel brucellosis higher than the seroprevalence found by this study (37.5%) was reported in Sudan [25]. It is known that the risk of the disease is higher in intensively reared animals due to increased exposure [26], and in this study, all sampled camels were from semi-intensively kept dairy camels, to which this relatively higher prevalence might be attributed. In addition to the lack of Brucella control programs in all domestic animals in Somalia, the free movement of camel herds and their contact with other herds and ruminants in the pasture and watering points can also contribute to the spread of Brucella infections. This finding shows that Brucella infection may pose a public health risk, as all sampled camels were apparently healthy animals from herds commercially reared for milk production.
The herd-level seroprevalence in this study was 54.2%. Few studies documenting herd-level seroprevalence of camel brucellosis have been conducted, and the majority of these studies reported high seroprevalence. For instance, 35.1%, 31.3%, and 10.23% herd-level seroprevalence were reported in Jordan, Somalia, and Ethiopia, respectively [9,15,27]. However, a herd-level seroprevalence of 1.5% was reported in Oman [4]. The present study focused on individual seroprevalence, and a small number of herds were sampled. Therefore, we recommend further studies on the herd-level seroprevalence of camel brucellosis in the study area.
The final binary logistic regression model in the present study revealed that, at the animal level, district, herd size, and contact with ruminants were significantly associated with camel brucellosis seropositivity.
District was statistically associated with Brucella seropositivity, whereby Galkayo district had a significantly higher seroprevalence of 10.3%, and camels in this district were about nine times more at risk of acquiring Brucella infection than camels in Bosaso district (p = 0.015; OR: 9.428; 95% CI: 1.539–57.755). Garowe district recorded relatively lower seroprevalence. These results corroborate those reported by Ghanem et al. (2009) in three districts in Somaliland, where the locality was significantly associated with the seropositive cases. Galkayo district is the capital of the Mudug region, central Somalia, which is bordered by Ethiopia to the west. Many camel herders who commercially kept camels in Galkayo district got their camels from Ethiopia, where the disease is endemic [28]. Moreover, the movement of camels between Somalia and Ethiopia is uncontrolled. These factors might explain this finding.
Farms with a large herd size (>50 camels) also showed statistically significant association with camel brucellosis, and were about six times more likely to have Brucella infection than farms with a small herd size (<50 camels) (p = 0.019; OR: 5.822; 95% CI: 1.336–25.371); similar observations have been reported by others [3,29,30,31]. In larger herds, more contact between camels may occur, especially during the calving season, which increases the chance of transmission of Brucella to susceptible camels.
Camels from herds that had contact with sheep and/or goats were also significantly associated with seropositivity for camel brucellosis, and were about 11 times more at risk than those who had contact with cattle (p = 0.011; OR: 10.941; 95% CI: 1.728–69.285). This suggests that B. melitensis may spill over from its small ruminant reservoir to camels, and might be due to the higher population density of sheep and goats in the study area, which share the pasture and watering points with camels, compared with the lower cattle population. The findings of our study are in agreement with those reported in Jordan [9].

5. Conclusions

The seroprevalence reported by the current study in the Puntland State of Somalia suggests that Brucella infection in camels is present in Galkayo, Bosaso, and Garowe districts. The risk factors influencing the seroprevalence of camel brucellosis at the animal level were district, herd size, and contact with ruminants. There is a need for further studies investigating brucellosis in ruminants and testing the correlation between brucellosis in camels and in ruminants. Studies focusing on the isolation of Brucella strains in camels in Somalia are also recommended. Moreover, serological assays, including c-ELISA, should be validated for Brucella antibody detection in camels. Further studies aiming at isolating Brucella spp. from camel milk would allow the tracing back of human infection in One Health approaches.

Author Contributions

Conceptualization, A.S.M. and J.B.M.; methodology, A.S.M.; software, A.S.M.; validation, A.S.M., J.B.M., R.L.M. and J.P.K.; formal analysis, A.S.M.; investigation, A.S.M.; resources, A.S.M.; data curation, A.S.M.; writing—original draft preparation, A.S.M.; writing—review and editing, J.B.M., R.L.M., J.P.K., M.M. and J.G.; visualization, A.S.M.; supervision, J.B.M.; project administration, A.S.M.; funding acquisition, J.B.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the African Centre of Excellence for Infectious Diseases in Humans and Animals (ACEIDHA) at the School of Veterinary Medicine, University of Zambia.

Institutional Review Board Statement

The study was approved by ethical committee at the Ministry of Livestock and Animal Husbandry, Puntland State of Somalia, and its ethical approval identification code is MoLAH/DG004/2020.

Informed Consent Statement

Prior to the sample collection, farmers were informed orally about the objectives of the study, data confidentiality, and that they were free to accept or refuse to participate in the study. Oral consent was used due to low levels of literacy among camel farmers, which may have influenced their ability to sign the written consent form.

Data Availability Statement

The data supporting the reported results can be made available on request from the corresponding author.

Acknowledgments

We are grateful to Farah Isse Mumin, Abdirahman Muse, Abdullahi Suleiman, Abdulgani Huruse, and Said Abdulkadir for their assistance in camel sampling and serum sample preparation in Somalia. We are also grateful to Penjani Kapila for his assistance in the laboratory analysis at the School of Veterinary Medicine, University of Zambia.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

References

  1. Faye, B. Role, Distribution and Perspective of Camel Breeding in the Third Millennium Economies. Emir. J. Food Agric. 2015, 27, 318–327. [Google Scholar] [CrossRef] [Green Version]
  2. Zewdie, W.W. Review on Epidemiology of Camel and Human Brucellosis in East Africa, Igad Member Countries. Sci. J. Clin. Med. 2017, 6, 109. [Google Scholar] [CrossRef] [Green Version]
  3. Ghanem, Y.M.; El-Khodery, S.A.; Saad, A.A.; Abdelkader, A.H.; Heybe, A.; Musse, Y.A. Seroprevalence of Camel Brucellosis (Camelus Dromedarius) in Somaliland. Trop. Anim. Health Prod. 2009, 41, 1779–1786. [Google Scholar] [CrossRef]
  4. Alrawahi, A.H.; Robertson, I.; Hussain, M.H.; Saqib, M. A Cross-Sectional Seroepidemiological Study of Camel (Camelus Dromedarius) Brucellosis and Associated Risk Factors in the Sultanate of Oman. Open Vet. J. 2019, 9, 133–139. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Corbel, M.J. Brucellosis in Humans and Animals; WHO: Geneva, Switzerland, 2006; pp. 1–102. [Google Scholar] [CrossRef] [Green Version]
  6. Gwida, M.M.; El-Gohary, A.H.; Melzer, F.; Tomaso, H.; Rösler, U.; Wernery, U.; Wernery, R.; Elschner, M.C.; Khan, I.; Eickhoff, M.; et al. Comparison of Diagnostic Tests for the Detection of Brucella spp. in Camel Sera. BMC Res. Notes 2011, 4, 1–7. [Google Scholar] [CrossRef] [Green Version]
  7. Gutema, F.; Tesfaye, J. Review on Camel Brucellosis: Public Health Importance and Status in Ethiopia. Acad. Res. J. Agric. Sci. Res. 2019, 7, 513–529. [Google Scholar] [CrossRef]
  8. Ibrahim, H.H.; Rouby, S.; Menshawy, A.; Ghazy, N. Seroprevalence of Camel Brucellosis and Molecular Characterization of Brucella Melitensis Recovered from Dromedary Camels in Egypt. Res. J. Vet. Pract. 2016, 4, 17–24. [Google Scholar] [CrossRef] [Green Version]
  9. Al-Majali, A.M.; Al-Qudah, K.M.; Al-Tarazi, Y.H.; Al-Rawashdeh, O.F. Risk Factors Associated with Camel Brucellosis in Jordan. Trop. Anim. Health Prod. 2008, 40, 193–200. [Google Scholar] [CrossRef]
  10. Khalafalla, A.I.; Rashid, J.; Khan, R.A.; Alamin, K.M.; Benkhelil, A.; De Massis, F.; Calistri, P.; Giovannini, A.; Khan, I.A.; Al Hosani, M.A.; et al. Preliminary Comparative Assessment of Brucellergene Skin Test for Diagnosis of Brucellosis in Dromedary Camels (Camelus Dromedarius). Vector-Borne Zoonotic Dis. 2020, 20, 412–417. [Google Scholar] [CrossRef] [PubMed]
  11. Falade, S.; Hussein, A.H. Short Communication Brucella sero-activity in somali goats. Vet. Microbiol. 1979, 11, 211–212. [Google Scholar]
  12. Ghanem, Y.M.; Sawalhy, A.E.; Saad, A.A.; Abdelkader, A.H.; Heybe, A. A Seroprevalence Study of Ovine and Caprine Brucellosis in Three Main Regions of Somaliland (Northern Somalia). Bull. Anim. Health Prod. Afr. 2010, 2, 233–244. [Google Scholar] [CrossRef]
  13. Ghanem, Y.M.; El Sawalhy, A.; Saad, A.A.; Abdelkader, A.H.; Heybe, A. A serosurvey of bovine brucellosis in three cattle-rearing regions of somaliland(northern somalia) Introduction Brucellosis Has a Considerable Impact on Animal and Human Health, as Well as Wide Socio-Economic Impacts, Especially in Countries in Which. Bull. Anim. Health Prod. Afr. 2010, 3, 221–231. [Google Scholar]
  14. Wernery, U.; Kerani, A.A.; Viertel, P. Bovine brucellosis in the southern regions of the somali democratic republic. Trop. Anim. Health Prod. 1979, 11, 31–32. [Google Scholar] [CrossRef] [PubMed]
  15. Kadle, A.A.H.; Mohamed, S.A.; Ibrahim, A.M.; Alawad, M.F. Sero-Epidemiological Study on Camel Brucellosis in Somalia. Eur. Acad. Res. 2017, V, 2925–2942. [Google Scholar]
  16. Oldfield, E.C.; Rodier, G.R.; Gray, G.C. Gray Source: Clinical Infectious Diseases; Edward, C., Oldfield, G.R., Rodier, G.C., Eds.; Endemic Infectious Diseases of Published by Oxford University; Oxford University Press: Oxford, UK, 1993; Volume 16, Supplement 3; p. 16. [Google Scholar]
  17. Ministry of Planning and International Cooperation. Puntland Facts and Figures. 2018. Available online: https://pl.statistics.so/puntland-facts-figures-2012-2017/ (accessed on 27 February 2020).
  18. Roy Behnke and David Muthami. The Contribution of Livestock to the Kenyan Economy. IGAD Livest. Policy Initiat. Work. Pap. 2013, 3–11, 1–62. [Google Scholar]
  19. Thrusfield, Michael. Veterinary Epidemiology. Equine Internal Medicine, 3rd ed.; Blackwell Science Ltd.: Oxford, UK, 2005. [Google Scholar] [CrossRef]
  20. Khan, A.U.; Sayour, A.E.; Melzer, F.; El-soally, S.A.G.E.; Elschner, M.C.; Shell, W.S.; Moawad, A.A.; Mohamed, S.A.; Hendam, A.; Roesler, U.; et al. Seroprevalence and Molecular Identification of Brucella spp. In Camels in Egypt. Microorganisms 2020, 8, 1035. [Google Scholar] [CrossRef]
  21. Sayour, A.E.; Elbauomy, E.M.; El-Kholi, M.K.; Shehata, A.A.E. Brucellosis Prevalence and Serologic Profile of Male One-Humped Camels Reared in Somaliland and Eastern Ethiopia for Meat Production. Glob. Vet. 2015, 14, 67–76. [Google Scholar] [CrossRef]
  22. Megersa, B.; Biffa, D.; Abunna, F.; Regassa, A.; Godfroid, J.; Skjerve, E. Seroprevalence of Brucellosis and Its Contribution to Abortion in Cattle, Camel, and Goat Kept under Pastoral Management in Borana, Ethiopia. Trop. Anim. Health Prod. 2011, 43, 651–656. [Google Scholar] [CrossRef]
  23. Hadush, A.; Pal, M.; Kassa, T.; Zeru, F. Sero-Epidemiology of Camel Brucellosis in the Afar Region of Northeast Ethiopia. J. Vet. Med. Anim. Health 2013, 5, 269–275. [Google Scholar] [CrossRef]
  24. Habtamu, T.T.; Richard, B.; Dana, H.; Kassaw, A.T. Camel Brucellosis: Its Public Health and Economic Impact in Pastoralists, Mehoni District, Southeastern Tigray, Ethiopia. J. Microbiol. Res. 2015, 5, 149–156. [Google Scholar] [CrossRef]
  25. Omer, M.M.; Musa, M.T.; Bakhiet, M.R.; Perrett, L. Brucellosis in Camels, Cattle and Humans: Associations and Evaluation of Serological Tests Used for Diagnosis of the Disease in Certain Nomadic Localities in Sudan. OIE Rev. Sci. Tech. 2010, 29, 663–669. [Google Scholar] [CrossRef] [Green Version]
  26. Gwida, M.; El-Gohary, A.; Melzer, F.; Khan, I.; Rösler, U.; Neubauer, H. Brucellosis in Camels. Res. Vet. Sci. 2012, 92, 351–355. [Google Scholar] [CrossRef] [PubMed]
  27. Mohammed, O.; Megersa, B.; Abebe, R.; Abera, M.; Regassa, A.; Abdrehman, Y.; Mekuria, S. Seroprevalence of Brucellosis in Camels in Ethiopia.Pdf. J. Anim. Vet. Adv. 2011, 10, 1177–1183. [Google Scholar]
  28. Lakew, A.; Hiko, A.; Abraha, A.; Hailu, S.M. Sero-Prevalence and Community Awareness on the Risks Associated with Livestock and Human Brucellosis in Selected Districts of Fafan Zone of Ethiopian-Somali National Regional State. Vet. Anim. Sci. 2019, 7, 100047. [Google Scholar] [CrossRef]
  29. Arif, S.; Thomson, P.C.; Hernandez-Jover, M.; McGill, D.M.; Warriach, H.M.; Heller, J. Knowledge, Attitudes and Practices (KAP) Relating to Brucellosis in Smallholder Dairy Farmers in Two Provinces in Pakistan. PLoS ONE 2017, 12, e0173365. [Google Scholar] [CrossRef]
  30. Corman, V.M.; Jores, J.; Meyer, B.; Younan, M.; Liljander, A.; Said, M.Y.; Gluecks, I.; Lattwein, E.; Bosch, B.J.; Drexler, J.F.; et al. Antibodies against MERS Coronavirus in Dromedary Camels, Kenya, 1992–2013. Emerg. Infect. Dis. 2014, 20, 1319–1322. [Google Scholar] [CrossRef] [PubMed]
  31. Dean, A.S.; Crump, L.; Greter, H.; Schelling, E.; Zinsstag, J. Global Burden of Human Brucellosis: A Systematic Review of Disease Frequency. PLoSNegl. Trop. Dis. 2012, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Table 1. Distribution and characteristics of sampled camels.
Table 1. Distribution and characteristics of sampled camels.
No. of Sampled CamelsHerd SizeAge
DistrictFemaleMaleTotalCategoryFrequency (%)Age GroupFrequency (%)
Galkayo16619185<50 animals10(41.7%)<2 years85(19.3%)
Garowe10040140>50 animals14(58.3%)2–5 years105(23.8%)
Bosaso8036116-->5 years251(56.9%)
Total34695441Total24(100%)Total441(100%)
Table 2. Seroprevalence of camel brucellosis.
Table 2. Seroprevalence of camel brucellosis.
Individual Level Brucellosis Seroprevalence
Sampled CamelsPositives%95% CI
441317%4.8–9.8%
Distribution of Brucellosis by Herd
No. of HerdsPositives%95% CI
241354.2%32.8–74.4%
Distribution of Brucellosis by District
DistrictSampled CamelsPositives (%)95% CI
Galkayo18519(10.3%)6.%3–15.6%
Garowe1402(1.4%)0.2–0.5.1%
Bosaso11610(8.6%)4.2–15.3%
Table 3. Risk factors for Brucella infection in camels at the individual level in univariate analysis.
Table 3. Risk factors for Brucella infection in camels at the individual level in univariate analysis.
Risk FactorCategoryBrucella SeropositivityX2p
NegativePositive
DistrictGalkayo
Garowe
Bosaso
166
138
106
19
2
10
10.1430.006
Introducing new camelsNo
Yes
214
196
7
24
10.1110.001
SexFemale
Male
321
89
25
6
0.0940.759
Age<2 years
2–5 years
>5 years
80
98
232
5
7
19
0.3040.859
Herd size<50 animals
>50 animals
135
257
6
25
2.4410.118
History of abortion in the herdNo
Yes
268
142
20
11
0.0090.924
Contact with ruminantsWith sheep and goats
With both small and large ruminants
123
287
14
17
3.0490.079
Table 4. Binary logistic regression analysis of risk factors for camel brucellosis at the individual level.
Table 4. Binary logistic regression analysis of risk factors for camel brucellosis at the individual level.
Variableß 1SE 2pOR 395% CI 4
District
Bosaso-----
Galkayo2.2440.9250.0159.4281.539–57.755
Garowe0.3451.2020.7741.4120.134–14.903
Herd size (>50 animals)1.7620.7510.0195.8221.336–25.371
Contact with small ruminants2.3930.9420.01110.9411.728–69.285
Constant−6.0831.5390.0000.002-
1 ß: regression coefficient; 2 SE: standard error; 3 OR: odds ratio; 4 CI: confidence interval.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mohamud, A.S.; Kothowa, J.P.; Mfune, R.L.; Mubanga, M.; Godfroid, J.; Muma, J.B. Seroprevalence and Risk Factors Associated with Brucella Infection in Camels in the Puntland State of Somalia. Vet. Sci. 2021, 8, 137. https://0-doi-org.brum.beds.ac.uk/10.3390/vetsci8070137

AMA Style

Mohamud AS, Kothowa JP, Mfune RL, Mubanga M, Godfroid J, Muma JB. Seroprevalence and Risk Factors Associated with Brucella Infection in Camels in the Puntland State of Somalia. Veterinary Sciences. 2021; 8(7):137. https://0-doi-org.brum.beds.ac.uk/10.3390/vetsci8070137

Chicago/Turabian Style

Mohamud, Ahmed Said, John Pilate Kothowa, Ruth Lindizyani Mfune, Melai Mubanga, Jacques Godfroid, and John B. Muma. 2021. "Seroprevalence and Risk Factors Associated with Brucella Infection in Camels in the Puntland State of Somalia" Veterinary Sciences 8, no. 7: 137. https://0-doi-org.brum.beds.ac.uk/10.3390/vetsci8070137

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop